Markets
Security ▼ | Price | % | Buy | Sell | Target price | Potential |
---|---|---|---|---|---|---|
StageZero Life Sciences Ltd. |
€0.016
17.04.24 |
-20.510% | 0 | 0 | - | - |
Staar Surgical Co. |
€38.28
31.05.24 |
1.410% | 12 | 1 | €49.33 | 28.859% |
Sqi Diagnostics Inc. |
€0.093
18.08.21 |
-2.110% | 0 | 0 | - | - |
Spire Healthcare Group plc |
€2.88
31.05.24 |
1.410% | 0 | 0 | - | - |
Spineway |
€0.001
26.02.24 |
-27.270% | 1 | 0 | €1.80 | 224900.000% |
Spineguard S.A. |
€0.22
31.05.24 |
-0.680% | 0 | 0 | - | - |
Spectrum Pharmaceuticals |
€0.95
31.07.23 |
-4.190% | 0 | 0 | - | - |
Spectral Medical Inc |
€0.31
31.05.24 |
-1.280% | 0 | 0 | - | - |
Spark Therapeutics |
€102.55
17.12.19 |
1.030% | 0 | 0 | - | - |
Sosei Group Corp |
€8.35
31.05.24 |
3.730% | 0 | 0 | - | - |
Sorrento Therapeutics Inc. |
€0.28
16.06.23 |
- | 0 | 0 | - | - |
Sophiris Bio Inc. |
€0.20
05.08.20 |
- | 0 | 0 | - | - |
Sonic Healthcare |
€15.05
31.05.24 |
1.070% | 0 | 0 | - | - |
Son.ho.un.adr 1/5 Sf -,05 |
€57.00
31.05.24 |
- | 0 | 0 | - | - |
Somnomed Ltd. |
€0.18
28.05.24 |
0.600% | 0 | 0 | - | - |
Solon Eiendom ASA |
€4.37
04.02.22 |
0.230% | 0 | 0 | - | - |
Soligenix Inc. |
€5.85
09.02.24 |
- | 0 | 0 | - | - |
Solasia Pharma KK |
€0.14
31.05.24 |
- | 0 | 0 | - | - |
Smith & Nephew plc ADR |
€23.00
31.05.24 |
- | 2 | 0 | - | - |
Smith & Nephew plc |
€11.84
31.05.24 |
0.470% | 1 | 0 | - | - |
Skinbiotherapeutics |
€0.087
31.05.24 |
-3.330% | 0 | 0 | - | - |
Sirona Biochem Corp. |
€0.038
31.05.24 |
13.040% | 0 | 0 | - | - |
Sintx Technologies Inc. |
€0.062
24.05.24 |
-16.890% | 0 | 0 | - | - |
Sinovac Biotech |
-
- |
- | 0 | 0 | - | - |
Sino Biopharmaceutical Ltd |
€0.33
31.05.24 |
1.490% | 0 | 0 | - | - |
Simulations Plus |
€34.00
30.09.21 |
4.290% | 1 | 0 | €46.58 | 37.010% |
Siloam International Hospitals Tbk PT |
€0.13
31.05.24 |
-4.320% | 0 | 0 | - | - |
Sihuan Pharmaceutical Holdings Group Ltd. |
€0.058
31.05.24 |
- | 0 | 0 | - | - |
Sierra Oncology Inc. |
€52.50
15.10.22 |
- | 0 | 0 | - | - |
Sientra Inc. |
€0.054
01.03.24 |
0.940% | 0 | 0 | - | - |